ABSTRACT Motivation: Various computational methods have been proposed to tackle the problem of predicting the peptide binding ability for a specific MHC molecule. These methods are based on known binding peptide sequences. However, current available peptide databases do not have very abundant amounts of examples and are highly redundant. Existing studies show that MHC molecules can be classified into supertypes in terms of peptide-binding specificities. Therefore, we first give a method for reducing the redundancy in a given dataset based on information entropy, then present a novel approach for prediction by learning a predictive model from a dataset of binders for not only the molecule of interest but also for other MHC molecules.
INTRODUCTION
Major histocompatibility complex (MHC) molecules bind short peptides from antigens and present them on the surface of a cell for recognition by T Cell Receptors (TCR) [For general information on MHC see Janeway et al. (2001) ]. The presented peptide and MHC complexes induce the naïve T Cells to proliferate and differentiate into armed effector T cells that help to remove the antigens. MHC molecules show high diversity in their selectivity of peptides, making it difficult for pathogens to escape immune response. Each different MHC molecule can bind a set of different peptides. As antigen recognition by MHC molecules is the prerequisite of cellular immune response, it is of great immunological importance to have the ability to accurately predict those peptides that bind to specific MHC molecules. The experimental identification of peptide binding affinity to MHC molecules requires a binding assay of each peptide, which is a time consuming and costly process. Therefore, a number of alternative research efforts have been carried out in an attempt to discover the laws of binding peptide sequence patterns. Past predictive approaches can be divided into two main groups: MHC molecule structure based approaches and binding peptide sequence based approaches. In the former case, the crystal structure of the MHC molecule is required, which may not be possible to obtain for many MHC molecules. In the latter approach, the sequences of peptides are studied in order to ascertain binding patterns. After the discovery of main anchor residues by pooling sequences (Falk et al., 1991) , secondary anchors (Ruppert et al., 1993) and peptide sequence motifs (Rammense et al., 1995) , position specific quantitative matrix methods have been proposed to predict the binding affinity of a given peptide. Quantitative matrices such as BIMAS, SYFPEITHI and RANKPEP are constructed by analyzing the amino acid frequency in the binding peptides during pool sequencing (Rammensee et al., 1999) , side chain scanning (Hammer et al., 1994; Parker et al., 1994; Gulukota et al., 1997) , by revealing positional amino acid preferences with the use of combinatorial peptide libraries (Udaka et al., 2000) , and sequence alignment of binding peptides (Reche et al., 2002) . Furthermore, machine learning based approaches, such as artificial neural network (ANN) (Gulukota et al., 1997; Brusic et al., 1998a) , hidden markov model (HMM) (Mamitsuka, 1998; Udaka et al., 2002) , classification and regression tree (CART) (Segal et al., 2001) and support vector machine (SVM) (Dönnes, and Elofsson 2002; Riedesel et al., 2004) , have been introduced. Several studies comparing the performance of quantitative matrix and machine learning based methods found that machine learning based methods need more training data than matrix based methods to achieve good performance. (Yu et al., 2002; Peters et al., 2003) .
To develop an effective computer model in a bioinformatics approach, we need to understand the characteristics of the biological data at hand (Brusic et al., 1998c (Brusic et al., , 1999 . There are several concerns regarding the MHC binder databases currently available. First, the number of peptides for each MHC molecule is very limited, due to high experimental costs. In addition, although it may be easy to find a new binder that is similar to an existing one, it is difficult to find a unique and completely new binder. For example, seven or eight amino acid positions out of the nine in peptides' sequences may be the same, such as 'ALAKAAYAV', an HLA-A Ã 0201 binder in MHCPEP (Brusic et al., 1998b) . Correspondingly, 10 peptides with the pattern 'ALAKAAXXV', where X is an amino acid, can easily be found in MHCPEP as well. In short, any currently available binder database is highly redundant. We thus need to reduce the redundancy of the current database, assuming that the true data space of peptide binders is more general.
Our work attempts to overcome these data issues.
(1) We give a new method for reducing the redundancy of an MHC binding peptide database. This method is based on entropy, and by reducing the redundancy we can obtain a dataset representing a general data space of MHC binders which is more representative than any existing database. (2) We propose a novel computational method for predicting MHC-binding peptides by learning the predictive model from both the binding data of the MHC molecule of interest, as well as other MHC molecules. Studies show that MHC molecules can be classified into a relatively few number of supertypes (superfamilies) in terms of binding specificities by different criteria, such as motifs (supermotifs) of binding peptides (Sette and Sidney, 1999) , amino acid sequence similarities (Cano et al., 1998; McKenzie et al., 1999) , functional pockets in the binding groove (Chelvanayagam, 1996; Zhang et al., 1998) , structural similarities (Doytchinova et al., 2004) and binding specificity matrices (Lund et al., 2004) . Different MHC alleles in the same supertype have highly similar structure in the main binding peptide pocket and bind largely overlapping sets of peptides, which is also recognized in chimpanzees (Bertoni et al., 1998) . Cross-reactive peptides are frequently observed in the process of cancers and infectious diseases (Bertoni et al., 1997; Doolan et al., 1997) . Specifically, Sette and Sidney (1999) divided HLA class I molecules into nine supertypes, A1, A2, A3, A24, B7, B27, B44, B58 and B62. Brusic et al. found that HLA class I binding data of multiple alleles in the same supertype could accurately predict binding peptides for alleles that have no experimental data available (Brusic et al., 2002; Srinivasan et al., 2004) . Sturniolo et al. (1999) made use of pocket profiles to build virtual matrices for predicting promiscuous HLA-DR ligands. In contrast to these studies, we combine the binding data of the MHC allele of interest with the binding data of another MHC allele, regardless of supertype, to improve prediction accuracy. Through this study, the effect of combining the binding data of two different alleles, in the same or different supertypes, can be examined.
We examine this novel idea for nonameric peptide binding prediction to 16 HLA-A molecules in four different supertypes with respect to several studies (Sette and Sidney, 1999; Lund et al., 2004) 
MATERIALS AND METHODS

Source data
In this study, HLA-A binding nonamers were collected from six public databases, MHCPEP (Brusic et al., 1998b) , SYFPEITHI (Rammensee et al., 1999) , FIMM (Schönbach et al., 2002) , MHCBN (Bhasin et al., 2003) , AntiJen (Blythe et al., 2002) and Ligand (Sathiamurthy et al., 2003) in March 2005, as well as from two private data sources (A. Sette, unpublished data; K. Udaka, unpublished data). Because of varying experimental conditions on binding assays, the real-valued binding affinity measurements produced by these different research groups are incompatible. Moreover, these values are often unavailable in these databases. Therefore, we make binary predictions on peptide binding ability to HLA-A molecules. After deleting peptides that have undetermined amino acids in their sequences and removing redundant peptides, our dataset consists of altogether 16 alleles in different supertypes. As shown in Table 1 , 12 of these that have no less than 95 distinct binding nonamers used in the combination experiment. Considering the lack of experimentally verified nonamers that do not bind MHC molecules, we note that it was estimated that <1% of any nonameric peptide would bind a particular MHC molecule (Udaka et al., 1995) and that randomly generated putative non-binding peptides have been Improving MHC binding peptide prediction used in other studies (Dönnes and Elofsson, 2002) . Therefore, we randomly generated putative non-binding nonamers from proteins in the human genome from the KEGG database (Kanehisa et al., 2004) , ensuring that they are distinct from the known binding peptides of the MHC molecules of interest.
Predictive model
We utilize the popular inductive learning algorithm C4.5, which generates a decision tree classifier for prediction (Quinlan, 1993) . The original technique of decision tree was established in the 1970s (Friedman, 1977; Quinlan, 1979) , and it has been developed and matured in 1990s. C4.5 is one of the most popular and basic decision tree learning methods. The learned results are comprehensive and easily understandable, which is important to allow further verification by biologists. We construct the prediction model using C4.5 release 8 (downloadable from http://www.rulequest.com/Personal/). The generation of a decision tree is a recursive data partitioning, and C4.5 maximizes information content to split data, i.e. it maximizes information entropy. We denote the instances in the binding class as positive instances, and those in the non-binding class as negative instances. In each MHC molecule's binding dataset, we set the ratio of positive to negative instances to 1:1 to obtain a balanced training dataset, shown to achieve better classifier performance than natural class distributions (Weiss and Provost, 2003) . We note that the main purpose of this research is to determine whether or not the predictive accuracy of peptide binding to the HLA molecule of interest could be improved by incorporating the binding data of other HLA molecules, as opposed to improving the performance of existing computational prediction models. That is to say, other computational methods such as HMM may easily be used to build the predictive model.
Evaluation
For each dataset of binding nonamers to an MHC molecule, we conduct 24 five-fold cross validation experiments. Prediction accuracy is the percentage of correctly identified instances out of all instances in the test set. The average prediction accuracy on the test sets over all 24 rounds is used to evaluate performance. That is, we build the predictive model 120 times to obtain an average prediction accuracy to reduce any bias in the random partitioning. In this way, each dataset S has a corresponding C4.5 model predictive accuracy that is calculated by 24 five-fold cross validations. The paired sample two-tailed t-test is used to compare the performance of two predictive models for the same test. If the t-value is larger than a certain value, say 3.373 when comparing two sets of 120 prediction accuracy values, then the performance of one model is statistically significant over the other at confidence level 99.9%.
Dataset combination
To describe the dataset combination procedure in detail, we first define two terms: base dataset and auxiliary dataset. The base dataset is the peptide binding dataset of the MHC molecule of interest. The auxiliary dataset is the peptide binding dataset of another MHC molecule, which will be added into the base dataset for improving the prediction accuracy of the MHC molecule of interest. The detailed procedure we used to combine the base and auxiliary datasets is as follows:
Input. A peptide binding dataset S a for MHC molecule A (base dataset), a peptide binding dataset S b for MHC molecule B (auxiliary dataset), and C4.5 program to build the predictive model (decision tree).
Output. The prediction accuracy before and after combination, and their corresponding t-value.
(1) Run 24 five-fold cross validation experiments on original data set S a .
That is, divide S a into a training set S training and a test set S testing .
(2) After training the predictive model M on S training using C4.5 with default settings, obtain the prediction accuracy A initial on S testing with M.
(3) Keeping S testing unchanged, add all instances of S b to S training except for the instances that already exist in S a , calling this the new training dataset S 0 training . Then train a new predictive model M 0 using C4.5 with default settings. Finally, predict the binding ability of peptides in testing set S testing with M 0 to obtain a new accuracy A combine .
(4) Evaluate all 120 pairs of A initial and A combine using the statistical t-test.
Note that it is important to maintain consistency between the base and auxiliary datasets. That is, since we verify accuracy improvement by combining these two datasets, the prediction accuracy of each dataset should be made the same. This prediction accuracy is controlled by reducing the redundancy of each dataset using a new technique which we describe in the next section.
Redundancy reduction
In general, redundancy reduction techniques enable predictive models to avoid overfitting and to reproduce well on unseen data. Different redundancy reduction techniques are already used in various studies on MHC peptide binding prediction (Yu et al., 2002; Dönnes and Elofsson, 2002; Buus et al., 2003; Nielsen et al., 2004) , but they tended to be rather ad hoc and primitive. Yu et al. (2002) simply removed all peptides from the training set that differed by only a single amino acid from the test peptides, Dönnes and Elofsson (2002) ensured that no two peptides shared more than four amino acids in the binding dataset, and Buus et al. (2003) discarded peptides whose pairwise alignment scores exceeded a given threshold. Nielsen et al. (2004) performed homology reduction to make sure no peptide in test set shared sequence identity >90% with the peptides in training set. On the other hand, we use the measurement of entropy from information theory to reduce redundancy in the binding peptides. Given a set S of binding peptides (without non-binding peptides) for a specific MHC molecule, we derive a 20 row · 9 column matrix C containing the count of each distinct amino acid occurring in a specific position in S. Denoting each element n ij in matrix C as the number of amino acid i occurring in position j among all peptides, and N as the total number of peptides in the set S, the entropy of dataset S is:
In our procedure, we repeat the process of removing the peptide that maximizes this entropy function. That is, we repeatedly select a set of N À 1 peptides from the set of N peptides and measure the information content to find the set that maximizes this measure. The maximization of information content by C4.5 to recursively partition the data is thus consistent with our approach of reducing the redundancy of a peptide dataset. Since the prediction accuracies need to be kept consistent during our experiments, for each HLA molecule's binding peptide dataset, we produce peptide binding datasets whose predictive accuracies from the 24 cross-validation runs are $80%.
Given a binding peptide dataset S of size N, the pseudocode for creating peptide binding dataset Set(A) at predictive accuracy level A (say 80%) from S is shown in Figure 1 . The specific percentage of peptides that are removed by redundancy reduction depends on the size of the initial dataset, the redundancy in the initial dataset, and the target prediction accuracy. In Table 2 , the number of instances in each dataset of each HLA molecule at 80% accuracy levels is listed.
Experimental procedure
Our experimental procedure consists the following:
(1) Preliminary experiments on controlled datasets. We carried out our experiments on two types of preliminary datasets: one combining homogeneous datasets (binding data from the same MHC molecule) and one incorporating a randomly generated dataset. Figure 2 , the base dataset S a is constructed by randomly selecting 200 nonameric peptides from the dataset S of all available nonamers that bind to the HLA-A Ã 0201 molecule (positive instances) and by randomly generating 200 nonameric peptides from the human genome database (negative instances). Then an auxiliary dataset S h is created similarly from S and the human genome database, ensuring that no peptide existing in S h is found in S a . S h is then added to S a , and two prediction accuracies A initial and A combine are obtained. To reduce any bias that may exist in the particular dataset selected, we generate S a and S h randomly 50 times to calculate a set of A initial and A combine values, which are then analyzed using the paired sample t-test.
Combining homogeneous datasets. As shown in
Combining random datasets. The base dataset is constructed in the same way as the base dataset in the previous section, but the secondary dataset is generated differently. To create an auxiliary random dataset S r , both the 200 positive and 200 negative instances, none of which occur in S a , are randomly generated from the human genome database. Furthermore, to investigate the effect of the size of combined random peptide binding datasets, eight random datasets S r1 ,S r2 , . . . , S r8 of varying sizes are generated: 200, 400, 800, 1200, 1600, 2000, 3000 and 4000. Each of these random datasets are then individually combined with the base dataset to calculate the prediction accuracy. These procedures are repeated 50 times to reduce bias.
(2) Main experiments combining peptide binding datasets of different HLA molecules. As the dataset of our focus, the peptide binding datasets of different HLA molecules at the same accuracy level, resulting from our redundancy reduction technique, are combined in pairs to analyze the effect of combination. All these datasets were examined under the same experimental procedure using our predictive model. We are especially interested in the HLA molecule pairs whose initial predictive accuracies improve after combination.
RESULTS
Preliminary experiments
Combining homogeneous datasets As illustrated in Table 3 , the prediction accuracy is improved significantly after incorporating S h into S a . The results of this experiment show that when two homogeneous datasets are combined together to build our predictive model, the predictive accuracy is improved significantly. Table 4 , incorporating a random dataset into the base dataset reduces the accuracy of prediction. As the size of the random datasets increase, the prediction accuracy of the combined datasets decrease correspondingly. The prediction accuracy of the combined peptide binding dataset decreases monotonically as the size of the added random dataset increases. The initial predication accuracy is 80.6.
Combining random datasets As shown in
From these preliminary experiments combining homogeneous and random datasets, we can see that adding a similar peptide binding dataset into the base dataset improves the predictive accuracy of our model, while adding random peptide binding datasets decreases performance.
Combining peptide binding datasets of different HLA molecules
We combined the datasets of two different HLA molecules at the same accuracy level. The result of the combination at accuracy level Improving MHC binding peptide prediction 80% is shown in Table 5 , which can be viewed as a prediction accuracy matrix A ij . In this matrix, cell a ii in the principal diagonal of the matrix represents the prediction accuracy of the dataset for the corresponding molecule before adding any auxiliary binding data. The other cells a ij represent the prediction accuracy of the HLA molecule at row i after incorporating the auxiliary dataset of the HLA molecule at column j. Each cell (except along the principal diagonal) contains not only the prediction accuracy after combination, but also the t-value in the paired sample t-test comparing prediction accuracy before and after combination over the 24 five-fold cross validation runs. If there exists a statistically significant difference (99.9% or above) in prediction accuracy before and after combination, the t-value is printed in bold. An improvement in the prediction accuracy at a statistically significant level (99.9% or above) is indicated by a bolded prediction accuracy value after combination. Our experimental results show that combining binding data of different types of molecules to improve prediction accuracy works in various combinations. Examining these cases, we are especially interested in HLA molecule pairs A and B such that the addition of the binding data of A to B improves the prediction accuracy of B, and vice versa. From these experimental results, we find that the improvement in prediction accuracy mainly comes from the combination of two alleles in the same supertype who have similar peptide binding specificities. Out of 40 statistically significantly improved combinations from all 132 possible combinations, 34 (85%) belong to the combination of two alleles in the same supertype. On the other hand, out of all 40 combinations of two alleles in the same supertype, 38 (95%) improve the original prediction accuracy, and 34 (85%) are statistically significant at the 99.9% level. Thus we next focus on the combinations of two alleles in the same supertype. In our experiment, there are only two supertypes that have more than two alleles, the A3 supertype ( On the other hand, the combination of two alleles in different supertypes can hardly improve the original prediction accuracy. Among all 92 of such possible combinations, only 6 (6.5%) improve the original prediction accuracies statistically significantly at the 99.9% level. We also find that the combination of peptide binding data of two alleles in the A2 and A3 supertypes, respectively, decreases the initial prediction accuracy significantly. One notable example is that the combination of A Ã 6801 and A Ã 6802 decreases the original prediction accuracy significantly. Although A Ã 6801 and A Ã 6802 belong to the same allotype, they have distinctly different peptide binding specificities and are classified into A3 and A2 supertype, respectively. Among the 50 possible combinations of two alleles each from the A2 and A3 supertypes, 48 (96%) decrease the initial prediction accuracies statistically significantly at the 99.9% level, implying that these alleles in two different supertypes differ greatly in peptide binding specificities. An interesting result came from the fact that the combination of A Ã 0101 and A Ã 0301, and A Ã 0101 and A Ã 1101, improve the original prediction accuracy. Since these alleles represent two different supertypes that are associated with somewhat different main anchor specificities, we believe that the improvements observed can be attributed to shared preferences at non-anchor positions. It has indeed been noted that A Ã 0101, A Ã 0301 and A Ã 1101 bear a close evolutionary kinship (McKenzie et al., 1999; Lawlor et al., 1990) . It has also been observed that mutation rates are faster at residues forming the main peptide binding pockets than at other sites along the peptide binding region (Sette and Hughes., 2003; Hughes and Hughes, 1995) . Together, these observations suggest that the similarities between A Ã 0101, A Ã 0301 and A Ã 1101 reflect their common ancestry.
Summary
Based on the experimental results at accuracy level 80%, we have three basic observations.
The combination of peptide binding data of HLA-A alleles in the same supertype, e.g. within the A2 or A3 supertypes, improves original prediction accuracy.
The combination of peptide binding data of HLA-A alleles in different supertypes hardly improves original prediction accuracy, and sometimes decreases statistically significantly.
Even though in different supertypes, the combinations of A Ã 0101 and A Ã 0301, A Ã 0101 and A Ã 1101 improved the original prediction accuracy. The initial prediction accuracy is 80.6 We also carried out combination experiment of different HLA molecules at accuracy level 75%, and obtained similar observations (see Supplementary information I). Furthermore, to verify the generalization of our method, we examined the performance of incorporating binding data of different HLA alleles in the same supertype by another predictive SVM model. Similar observations were obtained and the experimental results are provided under Supplementary information II. In addition, we explored the sequence similarity of different peptide binding datasets during combination. The experimental results are provided in Supplementary information III. We show that the sequence similarity of binding peptide datasets of the alleles in the same supertype is significantly higher than those in different supertypes, which helps to explain the improvement in prediction accuracy after incorporating the binding data of alleles in the same supertype.
DISCUSSION
Incorporating new data for predicting MHC binding peptide has also been examined by other researchers. Yu et al. found that with more training data, the performance of a prediction system by ANN and HMM could be improved in general (Yu et al., 2002) . Brusic et al. cyclically refined the predictive model to improve prediction accuracy by inclusion of new data (Brusic et al., 2001) , i.e. the binding data of the MHC molecule of interest. On the other hand, to predict binding peptide to the MHC molecule without experimental data, some researchers incorporated binding data of MHC molecules in the same supertype (Brusic et al., 2002; Srinivasan et al., 2004) . To verify their proposed supertypes of HLA class I alleles, Lund et al. (2004) used the peptide binding weight matrices of HLA molecules to predict the binding affinity of peptides to other HLA molecules in the same supertype. They found that the predictive value is positively correlated with experimental value. In contrast to these studies, with original binding data, we further combine the binding data of other MHC molecules that belong to any supertype, whether it be the same or different supertype. In this way, the effect of combining peptide binding data of two different MHC molecules in the same or different supertype is examined. From the experimental results, we find that combining binding data of two MHC molecules in the same supertype usually improves the prediction accuracy. Thus the key in improving prediction accuracy is to identify the group of MHC molecules with similar peptide binding specificities.
The development of vaccines that can cover a broad distribution of the human population stimulates researchers to classify HLA alleles into supertypes with similar specificities. Based on supermotifs shared by different HLA molecules, Sette and Sidney (1999) reported nine supertypes (A1, A2, A3, A24, B7, B27, B44, B58, B62) in HLA Class I molecules. For example, the HLA alleles in A3 supertype prefer A, V, I, L, M, S or T in position 2, and R, K or Y at the C-terminus. The HLA alleles in A2 supertype prefer to L, I, V, M, A, T or Q at position 2, and L, I, V, M, A or T at the C-terminal position. This evidence can explain the improvement of prediction accuracy in our experiment of combining peptide binding data of alleles in the same A2 or A3 supertype, and the decrease of prediction accuracy when combining peptide binding data of two alleles respectively in A2 and A3 supertype. This work also sheds light on the study of evolution of HLA class I genes. In a review article Klein et al. (1993) indicated that the evolution of MHC molecules has occurred through accumulated mutations, and they compared the evolutionary rate of MHC class I with that of class II. Many studies found that there are many gene conversions in HLA class I molecules (Hughes et al., 1993; Parham et al., 1988) . In addition, it was reported in Hughes et al. (1993) that HLA-A Ã 0101, A Ã 0301 and A Ã 1101 are all close to each other in terms of evolution. More often than HLA class II genes, HLA class I genes have exploited gene conversion like recombination events in order to transplant an anchor preference en bloc. Although this appears to have been a rather effective tactic in changing the anchor amino acids, the present analysis of binding similarities between A Ã 0101, A Ã 0301 and A Ã 1101 may show that HLA evolution is still a slow process carried on over a substantial part of the repertoire.
In this article, we have proposed a new approach for predicting binders to an MHC molecule by incorporating auxiliary peptide binding data from other MHC molecules. We have also presented a method for reducing redundancy in a set of binding peptides. Our experimental results show that our approach significantly improves the accuracy of predicting peptides binding an MHC molecule, especially when the base and auxiliary molecules belong to the same supertype having similar peptide binding specificities. Interesting future work should explore the effect of the combination of binding data from multiple alleles in the same supertype.
